Baseline characteristics of the study population.

AA, aldosterone receptor antagonist; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BB, beta-blocker; BMI, body mass index; BNP, b-type natriuretic peptide; BUN, blood urea nitrogen; CABG, coronary bypass graft surgery; CK-MB, creatine kinase-MB fraction; DBP, diastolic blood pressure; ECG, electrocardiography; HR, heart rate; IQR, interquartile range; LA AP, left atrium anterior-posterior; LBBB, left bundle branch block; LVEDD, left ventricular end diastolic dimension; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal-proBNP; NYHA, New York Heart Association; PAOD, peripheral artery obstructive disease; PCI, percutaneous coronary intervention; PTCA, percutaneous transluminal coronary angioplasty; SBP, systolic blood pressure; SD, standard deviation